| 缩写名/全名 |
EXPERT REV PROTEOMIC
Expert Review of Proteomics |
||||||||||||||||||||
| ISSN号 | 1478-9450 | ||||||||||||||||||||
| 研究方向 | 生物-生化研究方法 | ||||||||||||||||||||
| 影响因子 | 2015:3.465, 2016:3.849, 2017:3.489, 2018:2.963, 2019:3.614, | ||||||||||||||||||||
| 出版国家 | ENGLAND | ||||||||||||||||||||
| 出版周期 | Bimonthly | ||||||||||||||||||||
| 年文章数 | 67 | ||||||||||||||||||||
| 出版年份 | 2004 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||
| 录用比例 | 一般 | ||||||||||||||||||||
| 投稿链接 | https://mc.manuscriptcentral.com/eru | ||||||||||||||||||||
| 投稿官网 | http://www.tandfonline.com/toc/ieru20/current#.V48d2Uz9cSQ | ||||||||||||||||||||
| h-index | 53 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1478-9450%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Mining for missed sORF-encoded peptides. Author: Yin X1,2, Jing Y3, Xu H1,4. Journal: Expert Rev Proteomics. 2019 Mar;16(3):257-266. doi: 10.1080/14789450.2019.1571919. Epub 2019 Feb 13. PubMed DOI |
| 2. | Prediction of lymph node metastasis in oral squamous cell carcinoma based on protein profile. Author: Yu B1,2, Cao W1,2, Zhang C1,2, Xia R2,3, Liu J2, Yan M1,2, Chen W1,2. Journal: Expert Rev Proteomics. 2019 Apr;16(4):363-373. doi: 10.1080/14789450.2019.1584039. Epub 2019 Mar 6. PubMed DOI |
| 3. | Molecular insights into cancer drug resistance from a proteomics perspective. Author: An Y1,2, Zhou L1, Huang Z1, Nice EC3, Zhang H2, Huang C1,2. Journal: Expert Rev Proteomics. 2019 May;16(5):413-429. doi: 10.1080/14789450.2019.1601561. Epub 2019 Apr 12. PubMed DOI |
| 4. | Deciphering nasopharyngeal carcinoma pathogenesis via proteomics. Author: Xiao Z1, Chen Z1. Journal: Expert Rev Proteomics. 2019 May 4:1-11. doi: 10.1080/14789450.2019.1615891. [Epub ahead of print] PubMed DOI |
| 5. | Improving early detection of cancers by profiling extracellular vesicles. Author: Ding D1, Han D1, Li J1,2, Tan W1,3,4. Journal: Expert Rev Proteomics. 2019 May 25. doi: 10.1080/14789450.2019.1624531. [Epub ahead of print] PubMed DOI |
| 6. | From proteomics to personalized medicine: the road ahead. Author: Nice EC. Journal: Expert Rev Proteomics. 2016 Apr;13(4):341-3. doi: 10.1586/14789450.2016.1158107. Epub 2016 Mar 17. No abstract available. PubMed |
| 7. | Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives. Author: Zhou L, Wang K, Li Q, Nice EC, Zhang H, Huang C. Journal: Expert Rev Proteomics. 2016 Apr;13(4):367-81. doi: 10.1586/14789450.2016.1159959. Epub 2016 Mar 16. PubMed |
| 8. | Proteomic profiling predicts drug response to novel targeted anticancer therapeutics. Author: Lin F, Li Z, Hua Y, Lim YP. Journal: Expert Rev Proteomics. 2016 Apr;13(4):411-20. doi: 10.1586/14789450.2016.1164043. PubMed |
| 9. | Chemistry-based functional proteomics for drug target deconvolution. Author: Wang K, Yang T, Wu Q, Zhao X, Nice EC, Huang C. Journal: Expert Rev Proteomics. 2012 Jun;9(3):293-310. doi: 10.1586/epr.12.19. PubMed |
| 10. | Quantitative proteomic strategies for the identification of microRNA targets. Author: Li C, Xiong Q, Zhang J, Ge F, Bi LJ. Journal: Expert Rev Proteomics. 2012 Oct;9(5):549-59. doi: 10.1586/epr.12.49. PubMed |
|
|
